Luna Maris, Menekse Göker, Jens M Debacker, Kathia De Man, Bliede Van den Broeck, Jo Van Dorpe, Koen Van de Vijver, Vincent Keereman, Christian Vanhove
{"title":"高分辨率标本 PET-CT 与组织病理学联合注册方法,提高对放射性示踪剂分布的洞察力。","authors":"Luna Maris, Menekse Göker, Jens M Debacker, Kathia De Man, Bliede Van den Broeck, Jo Van Dorpe, Koen Van de Vijver, Vincent Keereman, Christian Vanhove","doi":"10.1186/s40658-024-00681-9","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>As the spatial resolution of positron emission tomography (PET) scanners improves, understanding of radiotracer distributions in tissues at high resolutions is important. Hence, we propose a method for co-registration of high-resolution ex vivo specimen PET images, combined with computed tomography (CT) images, and the corresponding specimen histopathology.</p><p><strong>Methods: </strong>We applied our co-registration method to breast cancer (BCa) specimens of patients who were preoperatively injected with 0.8 MBq/kg [ <math><mmultiscripts><mrow></mrow> <mrow></mrow> <mn>18</mn></mmultiscripts> </math> F]fluorodeoxyglucose ([<sup>18</sup>F]FDG). The method has two components. First, we used an image acquisition scheme that minimises and tracks tissue deformation: (1) We acquired sub-millimetre (micro)-PET-CT images of ±2 mm-thick lamellas of the fresh specimens, enclosed in tissue cassettes. (2) We acquired micro-CT images of the same lamellas after formalin fixation to visualise tissue deformation. (3) We obtained 1 hematoxylin and eosin (H&E) stained histopathology section per lamella of which we captured a digital whole slide image (WSI). Second, we developed an automatic co-registration algorithm to improve the alignment between the micro-PET-CT images and WSIs, guided by the micro-CT of the fixated lamellas. To estimate the spatial co-registration error, we calculated the distance between corresponding microcalcifications in the micro-CTs and WSIs. The co-registered images allowed to study standardised uptake values (SUVs) of different breast tissues, as identified on the WSIs by a pathologist.</p><p><strong>Results: </strong>We imaged 22 BCa specimens, 13 cases of invasive carcinoma of no special type (NST), 6 of invasive lobular carcinoma (ILC), and 3 of ductal carcinoma in situ (DCIS). While the cassette framework minimised tissue deformation, the best alignment between the micro-PET-CT images and WSIs was achieved after deformable co-registration. We found an overall average co-registration error of 0.74 ± 0.17 mm between the micro-PET images and WSIs. (Pre)malignant tissue (including NST, ILC, and DCIS) generally showed higher SUVs than healthy tissue (including healthy glandular, connective, and adipose tissue). As expected, inflamed tissue and skin also showed high uptake.</p><p><strong>Conclusions: </strong>We developed a method to co-register micro-PET-CT images of surgical specimens and WSIs with an accuracy comparable to the spatial resolution of the micro-PET images. While currently, we only applied this method to BCa specimens, we believe this method is applicable to a wide range of specimens and radiotracers, providing insight into distributions of (new) radiotracers in human malignancies at a sub-millimetre resolution.</p>","PeriodicalId":11559,"journal":{"name":"EJNMMI Physics","volume":"11 1","pages":"85"},"PeriodicalIF":3.0000,"publicationDate":"2024-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11473743/pdf/","citationCount":"0","resultStr":"{\"title\":\"Method for co-registration of high-resolution specimen PET-CT with histopathology to improve insight into radiotracer distributions.\",\"authors\":\"Luna Maris, Menekse Göker, Jens M Debacker, Kathia De Man, Bliede Van den Broeck, Jo Van Dorpe, Koen Van de Vijver, Vincent Keereman, Christian Vanhove\",\"doi\":\"10.1186/s40658-024-00681-9\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>As the spatial resolution of positron emission tomography (PET) scanners improves, understanding of radiotracer distributions in tissues at high resolutions is important. Hence, we propose a method for co-registration of high-resolution ex vivo specimen PET images, combined with computed tomography (CT) images, and the corresponding specimen histopathology.</p><p><strong>Methods: </strong>We applied our co-registration method to breast cancer (BCa) specimens of patients who were preoperatively injected with 0.8 MBq/kg [ <math><mmultiscripts><mrow></mrow> <mrow></mrow> <mn>18</mn></mmultiscripts> </math> F]fluorodeoxyglucose ([<sup>18</sup>F]FDG). The method has two components. First, we used an image acquisition scheme that minimises and tracks tissue deformation: (1) We acquired sub-millimetre (micro)-PET-CT images of ±2 mm-thick lamellas of the fresh specimens, enclosed in tissue cassettes. (2) We acquired micro-CT images of the same lamellas after formalin fixation to visualise tissue deformation. (3) We obtained 1 hematoxylin and eosin (H&E) stained histopathology section per lamella of which we captured a digital whole slide image (WSI). Second, we developed an automatic co-registration algorithm to improve the alignment between the micro-PET-CT images and WSIs, guided by the micro-CT of the fixated lamellas. To estimate the spatial co-registration error, we calculated the distance between corresponding microcalcifications in the micro-CTs and WSIs. The co-registered images allowed to study standardised uptake values (SUVs) of different breast tissues, as identified on the WSIs by a pathologist.</p><p><strong>Results: </strong>We imaged 22 BCa specimens, 13 cases of invasive carcinoma of no special type (NST), 6 of invasive lobular carcinoma (ILC), and 3 of ductal carcinoma in situ (DCIS). While the cassette framework minimised tissue deformation, the best alignment between the micro-PET-CT images and WSIs was achieved after deformable co-registration. We found an overall average co-registration error of 0.74 ± 0.17 mm between the micro-PET images and WSIs. (Pre)malignant tissue (including NST, ILC, and DCIS) generally showed higher SUVs than healthy tissue (including healthy glandular, connective, and adipose tissue). As expected, inflamed tissue and skin also showed high uptake.</p><p><strong>Conclusions: </strong>We developed a method to co-register micro-PET-CT images of surgical specimens and WSIs with an accuracy comparable to the spatial resolution of the micro-PET images. While currently, we only applied this method to BCa specimens, we believe this method is applicable to a wide range of specimens and radiotracers, providing insight into distributions of (new) radiotracers in human malignancies at a sub-millimetre resolution.</p>\",\"PeriodicalId\":11559,\"journal\":{\"name\":\"EJNMMI Physics\",\"volume\":\"11 1\",\"pages\":\"85\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2024-10-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11473743/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"EJNMMI Physics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1186/s40658-024-00681-9\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"EJNMMI Physics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s40658-024-00681-9","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0
摘要
背景:随着正电子发射层析(PET)扫描仪空间分辨率的提高,在高分辨率下了解放射性示踪剂在组织中的分布非常重要。因此,我们提出了一种结合计算机断层扫描(CT)图像和相应标本组织病理学的高分辨率体外标本 PET 图像共同配准方法:方法:我们对术前注射了 0.8 MBq/kg [ 18 F] 氟脱氧葡萄糖([18F]FDG)的乳腺癌(BCa)患者标本采用了我们的联合注册方法。该方法由两部分组成。首先,我们采用了一种可最大限度减少和跟踪组织变形的图像采集方案:(1)我们采集了装在组织盒中、厚度为±2 毫米的新鲜标本薄片的亚毫米(micro)-PET-CT 图像。(2)我们采集了福尔马林固定后的相同薄片的显微-CT 图像,以观察组织变形。(3)我们为每个薄片采集了一个苏木精和伊红(H&E)染色的组织病理学切片,并采集了数字化的全切片图像(WSI)。其次,我们开发了一种自动配准算法,以固定薄片的显微 CT 为指导,改进显微 PET-CT 图像与 WSI 之间的配准。为了估计空间配准误差,我们计算了显微CT和WSI中相应微钙化之间的距离。根据病理学家在 WSIs 上的鉴定结果,通过共聚合图像可以研究不同乳腺组织的标准化摄取值 (SUV):我们对 22 例 BCa 标本进行了成像,其中 13 例为无特殊类型浸润性癌 (NST),6 例为浸润性小叶癌 (ILC),3 例为导管原位癌 (DCIS)。虽然盒式框架最大程度地减少了组织变形,但显微 PET-CT 图像和 WSI 之间的最佳配准是在可变形共配准之后实现的。我们发现 micro-PET 图像和 WSI 之间的总体平均配准误差为 0.74 ± 0.17 毫米。(恶性肿瘤前组织(包括 NST、ILC 和 DCIS)的 SUV 值普遍高于健康组织(包括健康的腺组织、结缔组织和脂肪组织)。正如预期的那样,炎症组织和皮肤也显示出较高的摄取率:结论:我们开发了一种方法来共同注册手术标本和 WSI 的 micro-PET-CT 图像,其精确度与 micro-PET 图像的空间分辨率相当。虽然目前我们只将这种方法应用于 BCa 标本,但我们相信这种方法适用于多种标本和放射性核素,能以亚毫米级分辨率深入了解(新)放射性核素在人类恶性肿瘤中的分布情况。
Method for co-registration of high-resolution specimen PET-CT with histopathology to improve insight into radiotracer distributions.
Background: As the spatial resolution of positron emission tomography (PET) scanners improves, understanding of radiotracer distributions in tissues at high resolutions is important. Hence, we propose a method for co-registration of high-resolution ex vivo specimen PET images, combined with computed tomography (CT) images, and the corresponding specimen histopathology.
Methods: We applied our co-registration method to breast cancer (BCa) specimens of patients who were preoperatively injected with 0.8 MBq/kg [ F]fluorodeoxyglucose ([18F]FDG). The method has two components. First, we used an image acquisition scheme that minimises and tracks tissue deformation: (1) We acquired sub-millimetre (micro)-PET-CT images of ±2 mm-thick lamellas of the fresh specimens, enclosed in tissue cassettes. (2) We acquired micro-CT images of the same lamellas after formalin fixation to visualise tissue deformation. (3) We obtained 1 hematoxylin and eosin (H&E) stained histopathology section per lamella of which we captured a digital whole slide image (WSI). Second, we developed an automatic co-registration algorithm to improve the alignment between the micro-PET-CT images and WSIs, guided by the micro-CT of the fixated lamellas. To estimate the spatial co-registration error, we calculated the distance between corresponding microcalcifications in the micro-CTs and WSIs. The co-registered images allowed to study standardised uptake values (SUVs) of different breast tissues, as identified on the WSIs by a pathologist.
Results: We imaged 22 BCa specimens, 13 cases of invasive carcinoma of no special type (NST), 6 of invasive lobular carcinoma (ILC), and 3 of ductal carcinoma in situ (DCIS). While the cassette framework minimised tissue deformation, the best alignment between the micro-PET-CT images and WSIs was achieved after deformable co-registration. We found an overall average co-registration error of 0.74 ± 0.17 mm between the micro-PET images and WSIs. (Pre)malignant tissue (including NST, ILC, and DCIS) generally showed higher SUVs than healthy tissue (including healthy glandular, connective, and adipose tissue). As expected, inflamed tissue and skin also showed high uptake.
Conclusions: We developed a method to co-register micro-PET-CT images of surgical specimens and WSIs with an accuracy comparable to the spatial resolution of the micro-PET images. While currently, we only applied this method to BCa specimens, we believe this method is applicable to a wide range of specimens and radiotracers, providing insight into distributions of (new) radiotracers in human malignancies at a sub-millimetre resolution.
期刊介绍:
EJNMMI Physics is an international platform for scientists, users and adopters of nuclear medicine with a particular interest in physics matters. As a companion journal to the European Journal of Nuclear Medicine and Molecular Imaging, this journal has a multi-disciplinary approach and welcomes original materials and studies with a focus on applied physics and mathematics as well as imaging systems engineering and prototyping in nuclear medicine. This includes physics-driven approaches or algorithms supported by physics that foster early clinical adoption of nuclear medicine imaging and therapy.